nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Carnitine—SLC22A16—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0713	0.14	CbGpPWpGaD
L-Carnitine—SLC22A8—Organic anion transport—SLC22A12—nephrolithiasis	0.0385	0.0758	CbGpPWpGaD
L-Carnitine—SLC22A4—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0264	0.0519	CbGpPWpGaD
L-Carnitine—SLC22A16—renal system—nephrolithiasis	0.0209	0.0618	CbGeAlD
L-Carnitine—SLC22A16—kidney—nephrolithiasis	0.0202	0.0598	CbGeAlD
L-Carnitine—SLC22A8—nephron—nephrolithiasis	0.0199	0.0586	CbGeAlD
L-Carnitine—SLC22A5—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0198	0.039	CbGpPWpGaD
L-Carnitine—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0179	0.0353	CbGpPWpGaD
L-Carnitine—CROT—nephron tubule—nephrolithiasis	0.0167	0.0492	CbGeAlD
L-Carnitine—Methacholine—CHRM3—nephrolithiasis	0.016	0.529	CrCbGaD
L-Carnitine—SLC22A8—urine—nephrolithiasis	0.0159	0.047	CbGeAlD
L-Carnitine—SLC25A20—nephron tubule—nephrolithiasis	0.0145	0.0428	CbGeAlD
L-Carnitine—Bethanechol—CHRM3—nephrolithiasis	0.0143	0.471	CrCbGaD
L-Carnitine—SLC22A16—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.0143	0.0281	CbGpPWpGaD
L-Carnitine—CROT—cortex of kidney—nephrolithiasis	0.0143	0.0421	CbGeAlD
L-Carnitine—CRAT—nephron tubule—nephrolithiasis	0.0141	0.0415	CbGeAlD
L-Carnitine—SLC22A16—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.0133	0.0261	CbGpPWpGaD
L-Carnitine—SLC25A20—renal system—nephrolithiasis	0.0132	0.0389	CbGeAlD
L-Carnitine—CRAT—renal system—nephrolithiasis	0.0128	0.0377	CbGeAlD
L-Carnitine—SLC25A20—cortex of kidney—nephrolithiasis	0.0124	0.0366	CbGeAlD
L-Carnitine—CRAT—kidney—nephrolithiasis	0.0124	0.0365	CbGeAlD
L-Carnitine—CRAT—cortex of kidney—nephrolithiasis	0.012	0.0355	CbGeAlD
L-Carnitine—XDH—Purine metabolism—APRT—nephrolithiasis	0.0114	0.0225	CbGpPWpGaD
L-Carnitine—CPT2—nephron tubule—nephrolithiasis	0.0108	0.0319	CbGeAlD
L-Carnitine—CPT1A—renal system—nephrolithiasis	0.0104	0.0306	CbGeAlD
L-Carnitine—CPT1A—kidney—nephrolithiasis	0.01	0.0296	CbGeAlD
L-Carnitine—CPT2—renal system—nephrolithiasis	0.00983	0.029	CbGeAlD
L-Carnitine—CPT2—kidney—nephrolithiasis	0.0095	0.0281	CbGeAlD
L-Carnitine—SLC22A16—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00937	0.0184	CbGpPWpGaD
L-Carnitine—CPT2—cortex of kidney—nephrolithiasis	0.00925	0.0273	CbGeAlD
L-Carnitine—SLC22A16—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00857	0.0168	CbGpPWpGaD
L-Carnitine—SLC22A16—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00857	0.0168	CbGpPWpGaD
L-Carnitine—XDH—renal system—nephrolithiasis	0.00765	0.0226	CbGeAlD
L-Carnitine—XDH—kidney—nephrolithiasis	0.0074	0.0219	CbGeAlD
L-Carnitine—SLC22A16—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00649	0.0128	CbGpPWpGaD
L-Carnitine—SLC22A16—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00649	0.0128	CbGpPWpGaD
L-Carnitine—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.00622	0.0509	CcSEcCtD
L-Carnitine—SLC22A16—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00604	0.0119	CbGpPWpGaD
L-Carnitine—SLC22A16—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00604	0.0119	CbGpPWpGaD
L-Carnitine—XDH—Nucleotide metabolism—APRT—nephrolithiasis	0.00574	0.0113	CbGpPWpGaD
L-Carnitine—SLC22A16—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00538	0.0106	CbGpPWpGaD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00534	0.0105	CbGpPWpGaD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00534	0.0105	CbGpPWpGaD
L-Carnitine—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00529	0.0104	CbGpPWpGaD
L-Carnitine—SLCO1B1—renal system—nephrolithiasis	0.00501	0.0148	CbGeAlD
L-Carnitine—Injury—Hydrochlorothiazide—nephrolithiasis	0.005	0.0409	CcSEcCtD
L-Carnitine—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00492	0.00966	CbGpPWpGaD
L-Carnitine—SLC22A4—nephron tubule—nephrolithiasis	0.0049	0.0145	CbGeAlD
L-Carnitine—MPO—renal system—nephrolithiasis	0.00487	0.0144	CbGeAlD
L-Carnitine—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00485	0.0397	CcSEcCtD
L-Carnitine—SLCO1B1—kidney—nephrolithiasis	0.00485	0.0143	CbGeAlD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00476	0.00936	CbGpPWpGaD
L-Carnitine—MPO—kidney—nephrolithiasis	0.00471	0.0139	CbGeAlD
L-Carnitine—SLC22A4—renal system—nephrolithiasis	0.00445	0.0131	CbGeAlD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00435	0.00856	CbGpPWpGaD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00435	0.00856	CbGpPWpGaD
L-Carnitine—SLC22A4—kidney—nephrolithiasis	0.0043	0.0127	CbGeAlD
L-Carnitine—SLC22A8—nephron tubule—nephrolithiasis	0.00429	0.0127	CbGeAlD
L-Carnitine—CES1—NRF2 pathway—SLC2A9—nephrolithiasis	0.00428	0.00841	CbGpPWpGaD
L-Carnitine—SLC22A4—cortex of kidney—nephrolithiasis	0.00419	0.0124	CbGeAlD
L-Carnitine—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00407	0.0333	CcSEcCtD
L-Carnitine—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00405	0.0332	CcSEcCtD
L-Carnitine—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00398	0.00781	CbGpPWpGaD
L-Carnitine—Influenza—Hydrochlorothiazide—nephrolithiasis	0.00397	0.0325	CcSEcCtD
L-Carnitine—SLC22A8—renal system—nephrolithiasis	0.0039	0.0115	CbGeAlD
L-Carnitine—SLC22A8—kidney—nephrolithiasis	0.00377	0.0111	CbGeAlD
L-Carnitine—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.0037	0.00726	CbGpPWpGaD
L-Carnitine—SLC22A8—cortex of kidney—nephrolithiasis	0.00367	0.0108	CbGeAlD
L-Carnitine—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00361	0.0296	CcSEcCtD
L-Carnitine—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.0036	0.00707	CbGpPWpGaD
L-Carnitine—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.00348	0.0285	CcSEcCtD
L-Carnitine—SLC22A4—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00347	0.00681	CbGpPWpGaD
L-Carnitine—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00344	0.0282	CcSEcCtD
L-Carnitine—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00334	0.00657	CbGpPWpGaD
L-Carnitine—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00332	0.0272	CcSEcCtD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.0033	0.00649	CbGpPWpGaD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.0033	0.00649	CbGpPWpGaD
L-Carnitine—SLC22A5—nephron tubule—nephrolithiasis	0.00324	0.00957	CbGeAlD
L-Carnitine—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00319	0.0261	CcSEcCtD
L-Carnitine—SLC22A4—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00317	0.00623	CbGpPWpGaD
L-Carnitine—SLC22A4—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00317	0.00623	CbGpPWpGaD
L-Carnitine—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00316	0.0258	CcSEcCtD
L-Carnitine—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00313	0.0256	CcSEcCtD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00307	0.00603	CbGpPWpGaD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00307	0.00603	CbGpPWpGaD
L-Carnitine—SLC22A5—renal system—nephrolithiasis	0.00295	0.0087	CbGeAlD
L-Carnitine—SLC22A5—kidney—nephrolithiasis	0.00285	0.00841	CbGeAlD
L-Carnitine—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00284	0.0232	CcSEcCtD
L-Carnitine—SLC22A5—cortex of kidney—nephrolithiasis	0.00277	0.00819	CbGeAlD
L-Carnitine—CROT—Metabolism—GRHPR—nephrolithiasis	0.00274	0.00538	CbGpPWpGaD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00273	0.00537	CbGpPWpGaD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00273	0.00537	CbGpPWpGaD
L-Carnitine—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00271	0.0222	CcSEcCtD
L-Carnitine—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00268	0.0219	CcSEcCtD
L-Carnitine—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00266	0.0218	CcSEcCtD
L-Carnitine—SLC22A5—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00261	0.00512	CbGpPWpGaD
L-Carnitine—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00256	0.0209	CcSEcCtD
L-Carnitine—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00249	0.0204	CcSEcCtD
L-Carnitine—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00245	0.02	CcSEcCtD
L-Carnitine—CROT—Metabolism—AGXT—nephrolithiasis	0.00244	0.00479	CbGpPWpGaD
L-Carnitine—Cough—Hydrochlorothiazide—nephrolithiasis	0.00241	0.0198	CcSEcCtD
L-Carnitine—SLC22A4—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.0024	0.00472	CbGpPWpGaD
L-Carnitine—SLC22A4—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.0024	0.00472	CbGpPWpGaD
L-Carnitine—SLC22A5—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00238	0.00468	CbGpPWpGaD
L-Carnitine—SLC22A5—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00238	0.00468	CbGpPWpGaD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00236	0.00463	CbGpPWpGaD
L-Carnitine—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00236	0.0193	CcSEcCtD
L-Carnitine—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00236	0.0193	CcSEcCtD
L-Carnitine—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00235	0.0192	CcSEcCtD
L-Carnitine—CRAT—Metabolism—GRHPR—nephrolithiasis	0.00233	0.00457	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—GRHPR—nephrolithiasis	0.00233	0.00457	CbGpPWpGaD
L-Carnitine—SLC22A4—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00223	0.00439	CbGpPWpGaD
L-Carnitine—SLC22A4—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00223	0.00439	CbGpPWpGaD
L-Carnitine—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.0022	0.018	CcSEcCtD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00219	0.0043	CbGpPWpGaD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00216	0.00424	CbGpPWpGaD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00216	0.00424	CbGpPWpGaD
L-Carnitine—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00215	0.0176	CcSEcCtD
L-Carnitine—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00211	0.0173	CcSEcCtD
L-Carnitine—CRAT—Metabolism—AGXT—nephrolithiasis	0.00207	0.00407	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—AGXT—nephrolithiasis	0.00207	0.00407	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—APRT—nephrolithiasis	0.00207	0.00407	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—SLC26A1—nephrolithiasis	0.00207	0.00407	CbGpPWpGaD
L-Carnitine—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00206	0.0168	CcSEcCtD
L-Carnitine—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00204	0.0167	CcSEcCtD
L-Carnitine—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00203	0.0166	CcSEcCtD
L-Carnitine—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00201	0.0165	CcSEcCtD
L-Carnitine—SLC22A4—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00199	0.00391	CbGpPWpGaD
L-Carnitine—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00199	0.0163	CcSEcCtD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00198	0.00388	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00198	0.00388	CbGpPWpGaD
L-Carnitine—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00196	0.0161	CcSEcCtD
L-Carnitine—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00193	0.0158	CcSEcCtD
L-Carnitine—Pain—Hydrochlorothiazide—nephrolithiasis	0.00193	0.0158	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00185	0.0151	CcSEcCtD
L-Carnitine—SLC22A5—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00181	0.00355	CbGpPWpGaD
L-Carnitine—SLC22A5—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00181	0.00355	CbGpPWpGaD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00179	0.00352	CbGpPWpGaD
L-Carnitine—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00179	0.0146	CcSEcCtD
L-Carnitine—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00179	0.0146	CcSEcCtD
L-Carnitine—CRAT—Metabolism—APRT—nephrolithiasis	0.00176	0.00346	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—SLC26A1—nephrolithiasis	0.00176	0.00346	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—SLC26A1—nephrolithiasis	0.00176	0.00346	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—APRT—nephrolithiasis	0.00176	0.00346	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00176	0.00346	CbGpPWpGaD
L-Carnitine—SLC22A5—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00168	0.0033	CbGpPWpGaD
L-Carnitine—SLC22A5—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00168	0.0033	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00166	0.0136	CcSEcCtD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00164	0.00322	CbGpPWpGaD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00164	0.00322	CbGpPWpGaD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00163	0.00321	CbGpPWpGaD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00163	0.00321	CbGpPWpGaD
L-Carnitine—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00162	0.0133	CcSEcCtD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00161	0.00317	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00161	0.00317	CbGpPWpGaD
L-Carnitine—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.0016	0.0131	CcSEcCtD
L-Carnitine—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00155	0.0127	CcSEcCtD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00152	0.00298	CbGpPWpGaD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00152	0.00298	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—GRHPR—nephrolithiasis	0.0015	0.00295	CbGpPWpGaD
L-Carnitine—SLC22A5—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.0015	0.00294	CbGpPWpGaD
L-Carnitine—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00149	0.0122	CcSEcCtD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00149	0.00292	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00149	0.00292	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—AQP1—nephrolithiasis	0.00148	0.0029	CbGpPWpGaD
L-Carnitine—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00144	0.0118	CcSEcCtD
L-Carnitine—Rash—Hydrochlorothiazide—nephrolithiasis	0.00142	0.0117	CcSEcCtD
L-Carnitine—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00142	0.0116	CcSEcCtD
L-Carnitine—Headache—Hydrochlorothiazide—nephrolithiasis	0.00141	0.0116	CcSEcCtD
L-Carnitine—SLC22A8—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00135	0.00266	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00134	0.00264	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00134	0.00264	CbGpPWpGaD
L-Carnitine—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00134	0.011	CcSEcCtD
L-Carnitine—CROT—Metabolism—CHRM3—nephrolithiasis	0.00134	0.00263	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—AGXT—nephrolithiasis	0.00134	0.00263	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00132	0.0026	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—AQP1—nephrolithiasis	0.00126	0.00247	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—AQP1—nephrolithiasis	0.00126	0.00247	CbGpPWpGaD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00124	0.00244	CbGpPWpGaD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00124	0.00244	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00122	0.0024	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00122	0.0024	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00121	0.00238	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00121	0.00238	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.0012	0.00235	CbGpPWpGaD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00115	0.00227	CbGpPWpGaD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00115	0.00227	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—APRT—nephrolithiasis	0.00114	0.00223	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—CHRM3—nephrolithiasis	0.00114	0.00223	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—SLC26A1—nephrolithiasis	0.00114	0.00223	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—CHRM3—nephrolithiasis	0.00114	0.00223	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00114	0.00223	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00114	0.00223	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.0011	0.00215	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.0011	0.00215	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GRHPR—nephrolithiasis	0.00104	0.00204	CbGpPWpGaD
L-Carnitine—SLCO1B1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00103	0.00202	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00102	0.00201	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00102	0.00201	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00101	0.00199	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00101	0.00199	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—AGXT—nephrolithiasis	0.000926	0.00182	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000918	0.0018	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000918	0.0018	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000909	0.00179	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000853	0.00168	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000853	0.00168	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000832	0.00163	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000832	0.00163	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00083	0.00163	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00083	0.00163	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—AQP1—nephrolithiasis	0.000809	0.00159	CbGpPWpGaD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000809	0.00159	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—SLC26A1—nephrolithiasis	0.000787	0.00155	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—APRT—nephrolithiasis	0.000787	0.00155	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000772	0.00152	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000772	0.00152	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000761	0.00149	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000761	0.00149	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CHRM3—nephrolithiasis	0.000732	0.00144	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GRHPR—nephrolithiasis	0.000688	0.00135	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000688	0.00135	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000688	0.00135	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00063	0.00124	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00063	0.00124	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—AGXT—nephrolithiasis	0.000613	0.00121	CbGpPWpGaD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000608	0.0012	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000586	0.00115	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000586	0.00115	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—AQP1—nephrolithiasis	0.000561	0.0011	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00055	0.00108	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000522	0.00103	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000522	0.00103	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—SLC26A1—nephrolithiasis	0.000522	0.00102	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—APRT—nephrolithiasis	0.000522	0.00102	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CHRM3—nephrolithiasis	0.000507	0.000997	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000418	0.000821	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—AQP1—nephrolithiasis	0.000372	0.00073	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GRHPR—nephrolithiasis	0.000362	0.000712	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CHRM3—nephrolithiasis	0.000336	0.00066	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—AGXT—nephrolithiasis	0.000323	0.000634	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—SLC26A1—nephrolithiasis	0.000274	0.000539	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—APRT—nephrolithiasis	0.000274	0.000539	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—AQP1—nephrolithiasis	0.000196	0.000384	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CHRM3—nephrolithiasis	0.000177	0.000348	CbGpPWpGaD
